GENNAO BIO
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology. GMAB is an adaptive technology that uses a novel, cell-penetrating antibody to non-covalently bind to and deliver therapeutic levels of a wide variety of nucleic acid payloads to select cells. This non-viral delivery platform is differentiated from traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and employs well-established manufacturing processes. Gennao Bio is developing this delivery system with an initial focus on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases.
GENNAO BIO
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2020-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gennao.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
CureDuchenne Ventures
CureDuchenne Ventures investment in Series A - Gennao Bio
OrbiMed
OrbiMed investment in Series A - Gennao Bio
Logos Capital
Logos Capital investment in Series A - Gennao Bio
Surveyor Capital
Surveyor Capital investment in Series A - Gennao Bio
Official Site Inspections
http://www.gennao.com
- Host name: 16.124.215.35.bc.googleusercontent.com
- IP address: 35.215.124.16
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
